---
title: "ESC 2023: Prolonged clopidogrel monotherapy after PCI in high-risk ACS patients reduces bleeding and ischaemic events"
date: "2023-08-28T09:30:37.000Z"
publishedDate: "28 août 2023"
summary: "Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischaemic events in acute coronary syndrome (ACS) patients at high risk for both types of events, findings of the OPT-BIRISK trial, presented at the Europeans Society of Cardiology (ESC) congress (25–28 August, Amsterdam, The Netherlands), have shown. Ya-Ling Han (General [&#8230;] The post ESC 2023: Prolonged clopidogrel monotherapy after PCI in high-risk ACS patients reduces bleeding and ischaemic events appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/opt-birisk-trial-esc-2023/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-08-28-esc-2023-prolonged-clopidogrel-monotherapy-after-pci-in-high-risk-acs-patients-reduces-bleeding-and-ischaemic-events"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/Yaling-Han.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/opt-birisk-trial-esc-2023/"
---

![ESC 2023: Prolonged clopidogrel monotherapy after PCI in high-risk ACS patients reduces bleeding and ischaemic events](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/Yaling-Han.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/opt-birisk-trial-esc-2023/*

## L’essentiel

Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischaemic events in acute coronary syndrome (ACS) patients at high risk for both types of events, findings of the OPT-BIRISK trial, presented at the Europeans Society of Cardiology (ESC) congress (25–28 August, Amsterdam, The Netherlands), have shown. Ya-Ling Han (General [&#8230;] The post ESC 2023: Prolonged clopidogrel monotherapy after PCI in high-risk ACS patients reduces bleeding and ischaemic events appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/opt-birisk-trial-esc-2023/
